Response to the Commentary of Naldi and Cazzaniga Entitled ‘Are All Screening Programmes Created Equal? The Case of Melanoma'

Publisher： Karger

E-ISSN： 1421-9832|232|3|383-383

ISSN： 1018-8665

Source： Dermatology, Vol.232, Iss.3, 2016-03, pp. : 383-383

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Author's Reply to the Response to the Commentary of Naldi and Cazzaniga Entitled ‘Are All Screening Programmes Created Equal? The Case of Melanoma'

Dermatology, Vol. 232, Iss. 3, 2016-04 ,pp. : 384-384

Karger

Access to resources Recommend Favorite

Are All Screening Programmes Created Equal? The Case of Melanoma

Dermatology, Vol. 231, Iss. 4, 2015-0 ,pp. : 294-296

Karger

Access to resources Recommend Favorite

Anal Mucosal Melanoma with KIT-Activating Mutation and Response to Imatinib Therapy – Case Report and Review of the Literature

Dermatology, Vol. 220, Iss. 1, 2009-12 ,pp. : 77-81

Karger

Access to resources Recommend Favorite

Response of Mucocutaneous Lesions to Rituximab in a Case of Melanoma Differentiation Antigen 5-Related Dermatomyositis

Dermatology, Vol. 225, Iss. 4, 2013-02 ,pp. : 376-380

Karger

Access to resources Recommend Favorite

Imiquimod, a Topical Immune Response Modifier, in the Treatment of Cutaneous Metastases of Malignant Melanoma

Dermatology, Vol. 205, Iss. 2, 2002-08 ,pp. : 135-138

Karger

Access to resources Recommend Favorite